Nuclear Medicine: Page 10

Pluvicto patient response criteria validated

By Will Morton

Doctors now have a reliable approach for determining whether prostate cancer patients are responding to prostate cancer treatment with Pluvicto, according to research published July 11 in Radiology.

July 11, 2023

SNMMI calls for clarity over Leqembi PET scans

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imagine (SNMMI) has called for clarity over whether amyloid PET scans will be covered for potential candidates for the new Alzheimer's disease drug Leqembi (lecanemab).

July 10, 2023

FDA grants full approval to Alzheimer's disease drug Leqembi

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has granted full approval for Eisai and Biogen's Alzheimer's disease drug Leqembi (lecanemab).

July 6, 2023

RaySearch touts selection by Taiwanese hospital

By AuntMinnie.com staff writers

RaySearch Laboratories is highlighting that the proton therapy machine vendor Sumitomo recently placed an order for the RayStation treatment planning system, which will be installed at the Taichung Veterans General Hospital in Taiwan.

July 6, 2023

Canada to invest $26.6M for medical isotope development

By AuntMinnie.com staff writers

The Canadian government will invest $26.6 million U.S. toward producing and distributing medical isotopes and radiopharmaceuticals.

June 29, 2023

SNMMI: PET/MRI shows link between brain receptors and obesity

By Will Morton

PET/MRI has shown that neuroreceptors in the brains of people with obesity appear to respond differently to food cues those who are not obese, according to research presented June 27 at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 28, 2023

Video from SNMMI: Sutcliffe discusses findings in Image of the Year

CHICAGO - In an interview at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, Julie Sutcliffe, PhD, discussed her group's award-winning research on theranostics for imaging and treatment of pancreatic cancer.

June 28, 2023

SNMMI meeting hosts almost 8K attendees

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted nearly 8,000 physicians, technologists, pharmacists, laboratory professionals, and scientists at its 2023 annual meeting held in Chicago.

June 27, 2023

Mullani receives SNMMI's de Hevesy award

By AuntMinnie.com staff writers

The Society for Nuclear Medicine and Molecular Imaging (SNMMI) has bestowed its Georg Charles de Hevesy Nuclear Pioneer Award on Nizar Mullani of 3Gen.

June 27, 2023

SNMMI: Tailored prostate cancer treatment improves outcomes

By Kate Madden Yee

Monitoring response during lutetium-177 prostate-specific membrane antigen radioligand therapy improves outcomes, according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in Chicago.

June 27, 2023

SNMMI: Theranostics method targets multiple cancers

By Amerigo Allegretto

A new radionuclide-based agent offers potential as a theranostics approach for targeting multiple cancers, suggest findings presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 27, 2023

Theranostics takes center stage at SNMMI 2023

CHICAGO - In an interview with AuntMinnie.com, Society of Nuclear Medicine and Molecular Imaging (SNMMI) President Munir Ghesani, MD, discussed highlights of the society's annual meeting.

June 27, 2023

Previous Page

Page 10 of 440

Next Page